Last updated on June 2018

Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC


Brief description of study

The purpose of this Phase IIIb study is to collect additional safety and efficacy data for the combination of ribociclib + letrozole in men and pre/postmenopausal women with HR+HER2- advanced breast cancer.

Clinical Study Identifier: NCT02941926

Contact Investigators or Research Sites near you

Start Over

Novartis Pharmaceuticals

Novartis Investigative Site
Prague 8, Czechia
0.46miles
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Praha, Czechia
2.73miles
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Prague 5, Czechia
5.27miles
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Praha 4, Czechia
6.69miles
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Praha 10, Czechia
8.5miles
  Connect »